The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The collaboration between CORONA and Ferring will cater to patients across India
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Subscribe To Our Newsletter & Stay Updated
